Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Discovery Park: Fast growing food safety testing firm Curtis Analytics relocates to Discovery Park

Fast-growing food safety testing firm Curtis Analytics has relocated to Discovery Park, the Life Sciences Opportunity Zone for ambitious and growing life sciences companies, taking advantage of its grow-on space and high specification facilities.

Read the rest of entry »

New Restriction on R&D Tax Claims from 1 April 2021

After an extended period of consultation, it has been confirmed that a new restriction on the amount of cash that SME companies can recover under R&D claims will come into force from 1 April this year (in fact for accounting periods which start after that date).

Read the rest of entry »

Ultromics receives FDA Clearance for a first-of-kind solution in Echocardiography to help clinicians diagnose disease

OXFORD, England, Jan.6,2021/ A world-first, AI powered, outcomes-driven, decision support tool – EchoGo Pro, has been cleared by the FDA and is now available to clinicians across the U.S. EchoGo Pro was trialed and validated in the UK and US, improving the diagnostic accuracy of clinicians for Coronary Artery Disease (CAD), the most common form of heart disease and leading cause of death in the U.S.

Read the rest of entry »

Quotient Sciences Acquires Arcinova, the UK-Based Contract Development and Manufacturing Organization

Feb. 9, 2021 – Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract development and manufacturing organization (CDMO). With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide.

Read the rest of entry »

AMSBIO: Patient-Derived Human Primary Cancer Cells

AMSBIO has expanded its range of primary human cancer cells sourced from a wide variety of tissue types that allow the study of cancer in a more in vivo like fashion.

Read the rest of entry »

Vaccitech Doses First Patient in HBV002, a Phase 1b/2a Clinical Trial of VTP300 immunotherapeutic candidate for Chronic HBV Patients

Oxford, UK – 1st February 2021 – Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced the dosing of the first patient in HBV002.

Read the rest of entry »

tranScrip announces landmark investment from Palatine Private Equity

tranScrip is delighted to announce a significant minority investment from Palatine Private Equity Impact Fund, which complements the existing investment of tranScrip’s own Partners. The deal is a landmark for tranScrip, underpinning its growth as a leading specialist service provider.

Read the rest of entry »

Oxford BioMedica: Prime Minister Boris Johnson formally opens Oxford Biomedica’s manufacturing facility Oxbox

Oxford Biomedica plc, a leading gene and cell therapy group, announced on 18 January that the Prime Minister Rt Hon Boris Johnson MP, has formally opened Oxford Biomedica’s new 84,000 sq ft manufacturing facility Oxbox based in Oxford, UK.

Read the rest of entry »

University of Birmingham Enterprise: New biomaterials can be ‘fine-tuned’ for medical applications

Researchers in the UK and the United States have succeeded in ‘fine tuning’ a new thermoplastic biomaterial to enable both the rate at which it degrades in the body and its mechanical properties to be controlled independently.

Read the rest of entry »

BioCity: Early-stage life science ventures invited to apply for specialist support ahead of investment rounds

BioCity, the pioneering life science incubator and business collective, Innovate UK, NIHR and NHS England and NHS Improvement’s SBRI Healthcare programme, today announced a new partnership to support early-stage life science ventures within the UK to get investment ready.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.